<DOC>
	<DOC>NCT01808612</DOC>
	<brief_summary>The purpose of this study is to evaluate the short-term efficacy and safety of Fluoxetine in Japanese adult participants with Major Depressive Disorder (MDD).</brief_summary>
	<brief_title>A Study of Fluoxetine in Major Depressive Disorder (MDD) Short-Term Dosing</brief_title>
	<detailed_description />
	<mesh_term>Disease</mesh_term>
	<mesh_term>Depressive Disorder</mesh_term>
	<mesh_term>Depression</mesh_term>
	<mesh_term>Depressive Disorder, Major</mesh_term>
	<mesh_term>Fluoxetine</mesh_term>
	<criteria>Outpatient Japanese participants diagnosed with MDD Diagnosis of moderate or greater severity of MDD Agree to abstain from sexual activity or to use a reliable method of birth control Judged to be reliable (agree to keep appointments for clinic visits and to undergo all tests and examinations required by the protocol) Have previously been exposed to fluoxetine (LY110140) for any indication in the past Significant suicidal risk Have a current or previous diagnosis of bipolar disorder, psychotic depression, schizophrenia or other psychotic disorder, anorexia, bulimia, obsessive compulsive disorder, or posttraumatic stress disorder Have a history of substance abuse or dependence within the past 6 months, excluding caffeine and nicotine Have initiated, stopped, or changed the type or intensity of psychotherapy within 6 weeks Have a history of electroconvulsive therapy (ECT), transcranial magnetic stimulation (TMS), or vagus nerve stimulation (VNS) within 1 year Have had treatment with a Monoamine oxidase inhibitor (MAOI) within 14 days Need to use thioridazine or pimozide during the study Have previously enrolled, completed, or withdrawn from this study Have a positive urine drug screen for drugs with abuse potential Female participants who are either pregnant, nursing, or have recently given birth, or male participants who are planning for their partners to be or become pregnant Have a history of seizure disorder Have frequent or severe allergic reactions to multiple medications Have a serious or unstable medical illness or condition, or psychological condition Participants deemed ineligible by the investigator or subinvestigator for other reasons</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2015</verification_date>
</DOC>